FundedIQ
Biotechnology

Rejoni: Funding, Investors & Team (Nov 2026)

At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.

www.rejoni.com LinkedIn Bedford, United States 1-10 employees
Biotechnology Health Care Health Diagnostics Medical Device
Total raised
$50.0M
Rounds
2
Latest
Undisclosed round
Jun 2026

Rejoni has raised $50.0M across 2 funding rounds on record, the most recent an undisclosed round of $25.0M announced in Jun 2026.

That round is above the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Rejoni Company Profile and Key Stats

Total funding raised
$50.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$25.0M in Jun 2026
Employees
1-10
reported band
Headquarters
Bedford, United States

Latest funding round on record: Jun 2026.

Rejoni Funding Rounds

Date
Round
Amount
Undisclosed round
$25.0M
Series B
$25.0M

Rejoni raised $25.0M in a Series B announced in Dec 2022.

3.5 years later, an undisclosed round of $25.0M was announced in Jun 2026.

Rejoni Founders and Leadership Team

Name
Role
Contact
John Nealon
Founder
—
Amarpreet Sawhney
CEO
—

No contact details are on record for this team yet.

Rejoni Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.8M
30,541
$7.8M

Rejoni's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Rejoni in Biotechnology and Bedford

Companies Similar to Rejoni

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Rejoni Funding FAQs

What does Rejoni do?

At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.

How much funding has Rejoni raised?

Rejoni has raised $50.0M across 2 rounds on record. The most recent is an undisclosed round of $25.0M announced in Jun 2026.

When did Rejoni last raise funding?

Rejoni's most recent funding round on record is an undisclosed round of $25.0M, announced in Jun 2026.

Who founded Rejoni?

FundedIQ lists John Nealon (Founder) at Rejoni.

Who is the CEO of Rejoni?

Amarpreet Sawhney is listed as CEO at Rejoni.

Where is Rejoni headquartered?

Rejoni is based in Bedford, Massachusetts, United States.

How many employees does Rejoni have?

Rejoni is in the 1-10 employee band.

How does Rejoni's funding compare to other Biotechnology startups?

Rejoni's latest round of $25.0M is above the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Rejoni Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rejoni is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.